91 related articles for article (PubMed ID: 6304572)
1. [Anti-tissue autoantibodies in malignant pulmonary neoplasms].
Ruffatti A; Visentin G; Giordano C; Bozzo R; De Silvestro G; Todesco S
Minerva Med; 1983 May; 74(22-23):1319-24. PubMed ID: 6304572
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
3. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity in the Lambert-Eaton myasthenic syndrome.
Lennon VA; Lambert EH; Whittingham S; Fairbanks V
Muscle Nerve; 1982; 5(9S):S21-5. PubMed ID: 6302494
[TBL] [Abstract][Full Text] [Related]
5. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
7. Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus.
Chang JY; Chiang CP; Hsiao CK; Sun A
J Oral Pathol Med; 2009 Jan; 38(1):48-54. PubMed ID: 18764857
[TBL] [Abstract][Full Text] [Related]
8. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
9. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
10. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
BMC Cancer; 2004 Sep; 4():66. PubMed ID: 15367333
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer.
Al-Shukaili A; Al-Jabri AA; Al-Moundhri MS
Saudi Med J; 2006 Dec; 27(12):1873-7. PubMed ID: 17143367
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
Dellen H; Seemayer NH
Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated immunoglobulins in pulmonary carcinoma.
Gerstl B; Eng LF; Bigbee JW
Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
15. Tissue antibodies in a healthy New Zealand population.
Bullock JY; Booth RJ; Wilson JD
N Z Med J; 1979 Jan; 89(627):11-3. PubMed ID: 311908
[TBL] [Abstract][Full Text] [Related]
16. [The distribution of HLA-system antigens in lung cancer patients].
Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
[TBL] [Abstract][Full Text] [Related]
17. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
19. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
[TBL] [Abstract][Full Text] [Related]
20. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
